Transition zone prostate cancer: Incremental value of diffusion-weighted endorectal MR imaging in tumor detection and assessment of aggressiveness

Radiology

Volumn 269, Issue 2, 2013, Pages 493-503

  Jung II, Sung ^a,b   Donati, Olivio F ^a,c   Vargas, Hebert A ^a   Goldman, Debra ^a   Hricak, Hedvig ^a   Akin, Oguz ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Konkuk University Hospital   (South Korea)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGGRESSIVENESS; ARTICLE; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INSTITUTIONAL REVIEW; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; MEDICAL RECORD; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION;

ADULT; AGED; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84886686048     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.13130029     Document Type: Article

References (37)

1. Augustin H, Erbersdobler A, Hammerer PG, Graefen M, Huland H. Prostate cancers in the transition zone: Part 2; clinical aspects. BJU Int 2004;94(9):1226-1229. (Pubitemid 40052082)
2. Augustin H, Hammerer PG, Blonski J, et al. Zonal location of prostate cancer: significance for disease-free survival after radical prostatectomy? Urology 2003;62(1):79-85. (Pubitemid 36802076)
3. D'Amico AV, Whittington R, Malkowicz SB, et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998;280(11):969-974. (Pubitemid 28445094)
4. Erbersdobler A, Augustin H, Schlomm T, Henke RP. Prostate cancers in the transition zone: Part 1; pathological aspects. BJU Int 2004;94(9):1221-1225. (Pubitemid 40052081)
5. Grignon DJ, Sakr WA. Zonal origin of prostatic adenocarcinoma: are there biologic differences between transition zone and peripheral zone adenocarcinomas of the prostate gland? J Cell Biochem Suppl 1994;19:267-269. (Pubitemid 24306478)
6. Noguchi M, Stamey TA, Neal JE, Yemoto CE. An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics. J Urol 2000;163(6):1751-1755. (Pubitemid 30366728)
7. Philip J, Manikandan R, Viswanathan P. Prostate cancers in the transition zone: part 2; clinical aspects. BJU Int 2005;95(6):909. (Pubitemid 40547236)
8. Sakai I, Harada K, Hara I, Eto H, Miyake H. A comparison of the biological features between prostate cancers arising in the transition and peripheral zones. BJU Int 2005;96(4):528-532. (Pubitemid 41224321)
9. Davis JW, Kim J, Ward JF, et al. Radical prostatectomy findings in patients predicted to have low-volume/low-grade prostate cancer diagnosed by extended-core biopsies: an analysis of volume and zonal distribution of tumour foci. BJU Int 2010;105(10):1386-1391.
10. Patel V, Merrick GS, Allen ZA, et al. The incidence of transition zone prostate cancer diagnosed by transperineal template-guided mapping biopsy: implications for treatment planning. Urology 2011;77(5):1148-1152.
11. Kabalin JN, McNeal JE, Price HM, Freiha FS, Stamey TA. Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: incidence, histology and morphometric observations. J Urol 1989;141(5):1091-1094; discussion 1093-1094. (Pubitemid 19124204)
12. McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988;12(12):897-906. (Pubitemid 19011040)
13. Haarer CF, Gopalan A, Tickoo SK, et al. Prostatic transition zone directed needle biopsies uncommonly sample clinically relevant transition zone tumors. J Urol 2009;182(4):1337-1341.
14. McNeal J, Noldus J. Limitations of transition zone needle biopsy findings in the prediction of transition zone cancer and tissue composition of benign nodular hyperplasia. Urology 1996;48(5):751-756. (Pubitemid 26398696)
15. Fink KG, Hutarew G, Esterbauer B, et al. Evaluation of transition zone and lateral sextant biopsies for prostate cancer detection after initial sextant biopsy. Urology 2003;61(4):748-753. (Pubitemid 36384967)
16. Akin O, Hricak H. Imaging of prostate cancer. Radiol Clin North Am 2007;45(1):207-222. (Pubitemid 44854046)
17. Choi YJ, Kim JK, Kim N, Kim KW, Choi EK, Cho KS. Functional MR imaging of prostate cancer. RadioGraphics 2007;27(1):63-75; discussion 75-77.
18. Hricak H, Choyke PL, Eberhardt SC, Leibel SA, Scardino PT. Imaging prostate cancer: a multidisciplinary perspective. Radiology 2007;243(1):28-53. (Pubitemid 46579693)
19. Vargas HA, Akin O, Shukla-Dave A, et al. Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study. Radiology 2012;265(2):478-487.
20. Vargas HA, Akin O, Franiel T, et al. Diffusionweighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. Radiology 2011;259(3):775-784.
21. Haider MA, van der Kwast TH, Tanguay J, et al. Combined T2-weighted and diffusionweighted MRI for localization of prostate cancer. AJR Am J Roentgenol 2007;189(2):323-328. (Pubitemid 47195916)
22. Hambrock T, Somford DM, Huisman HJ, et al. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology 2011;259(2):453-461.
23. Lim HK, Kim JK, Kim KA, Cho KS. Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection-a multireader study. Radiology 2009;250(1):145-151.
24. Akin O, Sala E, Moskowitz CS, et al. Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging. Radiology 2006;239(3):784-792. (Pubitemid 43830614)
25. Mazaheri Y, Shukla-Dave A, Hricak H, et al. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging-correlation with pathologic findings. Radiology 2008;246(2):480-488.
26. Villers A, McNeal JE, Freiha FS, Stamey TA. Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors. Cancer 1992;70(9):2313-2318.
27. Oto A, Kayhan A, Jiang Y, et al. Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrastenhanced MR imaging. Radiology 2010;257(3):715-723.
28. Bouyé S, Potiron E, Puech P, Leroy X, Lemaitre L, Villers A. Transition zone and anterior stromal prostate cancers: zone of origin and intraprostatic patterns of spread at histopathology. Prostate 2009;69(1):105-113.
29. Leisenring W, Alonzo T, Pepe MS. Comparisons of predictive values of binary medical diagnostic tests for paired designs. Biometrics 2000;56(2):345-351. (Pubitemid 30422620)
30. Obuchowski NA. Nonparametric analysis of clustered ROC curve data. Biometrics 1997;53(2):567-578. (Pubitemid 27262219)
31. Cohen J. Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 1968;70(4):213-220.
32. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33(1):159-174. (Pubitemid 8054849)
33. Kim CK, Park BK, Han JJ, Kang TW, Lee HM. Diffusion-weighted imaging of the prostate at 3 T for differentiation of malignant and benign tissue in transition and peripheral zones: preliminary results. J Comput Assist Tomogr 2007;31(3):449-454. (Pubitemid 46849917)
34. Kim JH, Kim JK, Park BW, Kim N, Cho KS. Apparent diffusion coefficient: prostate cancer versus noncancerous tissue according to anatomical region. J Magn Reson Imaging 2008;28(5):1173-1179.
35. Verma S, Rajesh A, Morales H, et al. Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy. AJR Am J Roentgenol 2011;196(2):374-381.
36. Sato C, Naganawa S, Nakamura T, et al. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate. J Magn Reson Imaging 2005;21(3):258-262. (Pubitemid 40280120)
37. Li H, Sugimura K, Kaji Y, et al. Conventional MRI capabilities in the diagnosis of prostate cancer in the transition zone. AJR Am J Roentgenol 2006;186(3):729-742. (Pubitemid 46100257)